Get started
NOVONESIS A/S (NOVOZYMES A/S)NOVONESIS A/S (NOVOZYMES A/S)NOVONESIS A/S (NOVOZYMES A/S)

NOVONESIS A/S (NOVOZYMES A/S)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

NZM chart


Full chart

NZM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪28.77 B‬ EUR
Dividend yield (indicated)
1.00%
Price to earnings Ratio (TTM)
100.87
Basic EPS (TTM)
0.69 EUR
Net income (FY)
‪319.53 M‬ EUR
Revenue (FY)
‪4.01 B‬ EUR
Shares float
‪412.45 M‬
Beta (1Y)
0.15

About NOVONESIS (NOVOZYMES A/S) B


Sector
Process Industries
Industry
Chemicals: Specialty
CEO
Ester Baiget
Website
novonesis.com
Headquarters
Lyngby
Novonesis (Novozymes A/S) engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Check out other big names from the same industry as NZM.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NZM news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.